SANOFI AVENTIS US FDA Approval NDA 017796

NDA 017796

SANOFI AVENTIS US

FDA Drug Application

Application #017796

Application Sponsors

NDA 017796SANOFI AVENTIS US

Marketing Status

Discontinued001

Application Products

001SYRUP;ORALEQ 500MG BASE/5ML0BRYRELPIPERAZINE CITRATE

CDER Filings

SANOFI AVENTIS US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17796
            [companyName] => SANOFI AVENTIS US
            [docInserts] => ["",""]
            [products] => [{"drugName":"BRYREL","activeIngredients":"PIPERAZINE CITRATE","strength":"EQ 500MG BASE\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BRYREL","submission":"PIPERAZINE CITRATE","actionType":"EQ 500MG BASE\/5ML","submissionClassification":"SYRUP;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.